Forum Markets, Inc. (FRMM)
6.00
+0.52
(+9.49%)
USD |
NASDAQ |
Aug 24, 16:00
6.00
0.00 (0.00%)
After-Hours: 20:00
Forum Markets Total Assets (Quarterly) : 159.03M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 159.03M |
| March 31, 2026 | 207.61M |
| December 31, 2025 | 306.94M |
| September 30, 2025 | 1.009B |
| June 30, 2025 | 10.71M |
| March 31, 2025 | 11.65M |
| December 31, 2024 | 13.97M |
| September 30, 2024 | 10.47M |
| June 30, 2024 | 3.911M |
| March 31, 2024 | 3.442M |
| December 31, 2023 | 5.260M |
| September 30, 2023 | 4.958M |
| June 30, 2023 | 13.67M |
| March 31, 2023 | 14.92M |
| December 31, 2022 | 35.31M |
| September 30, 2022 | 34.34M |
| June 30, 2022 | 53.36M |
| March 31, 2022 | 59.68M |
| December 31, 2021 | 72.43M |
| Date | Value |
|---|---|
| September 30, 2021 | 65.07M |
| June 30, 2021 | 56.27M |
| March 31, 2021 | 60.11M |
| December 31, 2020 | |
| September 30, 2020 | 11.02M |
| June 30, 2020 | 12.63M |
| March 31, 2020 | 12.37M |
| December 31, 2019 | 12.50M |
| September 30, 2019 | 51.57M |
| June 30, 2019 | 50.24M |
| March 31, 2019 | 66.47M |
| December 31, 2018 | 118.44M |
| September 30, 2018 | 118.22M |
| June 30, 2018 | 117.95M |
| March 31, 2018 | 117.31M |
| December 31, 2017 | 117.06M |
| September 30, 2017 | 117.03M |
| June 30, 2017 | 116.81M |
| March 31, 2017 | 0.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 179.51M |
| Corcept Therapeutics, Inc. | 888.70M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.23M |
| Shareholders Equity (Quarterly) | 127.80M |
| Debt to Equity Ratio | 0.203 |
| Current Ratio | 2.688 |
| Net Debt Paydown Yield | -7.19% |